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Abstract 
Background: Restless Legs Syndrome (RLS) is characterized by uncomfortable nocturnal sensations 
in the legs making sedentary activities and sleep difficult, and thus is  linked with psychosocial 
distress. Due to the symptomatology and neurobiology of RLS (disrupting brain iron and dopamine) it 
is likely that RLS associates with poorer health-related quality of life (HRQL) and depressive 
disorder. The objective of this study was to investigate the RLS-HRQL and the RLS-depressive 
disorder links in a generally healthy population that is not biased by medications.  
Methods: Complete data, including the Cambridge-Hopkins RLS questionnaire, the 12-item short-
form standardized health survey (SF-12), the Major Depression Inventory (MDI), body mass index, 
smoking status, alcohol consumption, and education were available for 24,707 participants enrolled in 
the Danish Blood Donor Study from May 1, 2015 to February 1, 2017. Information on quality of sleep 
was available for all RLS cases. T-tests and multivariable logistic regression models were applied to 
examine the associations of RLS and MDI scores, and the physical and mental component scores 
(PCS and MCS) of SF-12, respectively. Analyses were conducted separately for men and women. 
Results: RLS associated with poorer MCS and poorer PCS. Moreover, Participants with RLS were 
more likely to classify with depressive disorder. Poor quality of sleep was associated with depressive 
disorder and poorer MCS among RLS cases, and with poorer PCS in female RLS cases. 
Conclusion: Thus, we demonstrated that RLS is associated with a significantly lower HRQL and a 
higher prevalence of depressive disorder among otherwise healthy individuals. 
Key words: Restless legs syndrome; RLS; WED; Willis-Ekbom; quality of life; depressive disorder; 
sleep disturbance; comorbidities; the Danish blood donor study 
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Highlights 
• Restless leg syndrome (RLS) is associated with increased depressive symptoms 
• RLS is associated with reduced health related quality of life 
• Poor quality of sleep increases the risk of these detrimental links among RLS cases 
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Restless Legs Syndrome (RLS) is a common neurological sensorimotor disorder with symptoms that 
include uncomfortable or painful sensations in the extremities, predominantly in the legs. Symptoms 
occur or become worse during rest and at night, therefore individuals with RLS often suffer from severe 
sleep disturbance [1, 2]. Previous studies have reported that RLS sufferers are more prone to 
experiencing inhibited cognitive functioning and psychosocial distress, including problems with social 
activities, family life, and occupational life due to fatigue following disruptions in sleep [3, 4]. 
Furthermore, associations between RLS and reduced health-related quality of life (HRQL) and 
increased depression, respectively, have been reported in several studies [1, 5-14]. The majority of these 
studies have included either a small population sample or participants with multiple medical problems 
plausibly linked with RLS, HRQL, or with depressive disorder. Thus, it is possible that the reported 
associations were biased by other diseases or medical treatments. For instance, it has been found that 
antidepressant medications exacerbate or provoke RLS symptoms [15]. However, due to the nature of 
the RLS symptomatology and neurobiology [14, 16] it is plausible that RLS and depression have a 
common etiology, as RLS has been linked with disruptions in major brain iron and therefore 
dysfunction in the dopaminergic system [17]. It may also be that the reduced HRQL and increased 
depression observed in RLS sufferers were caused by RLS-related sleep problems. Furthermore, HRQL 
can be divided into two components: mental HRQL (MCS) and physical HRQL (PCS), which are both 
likely to be negatively affected by RLS, but perhaps in different ways. It is well-known that the RLS 
disorder varies greatly between sufferers in intensity, herein both severity and frequency of the 
symptoms, and we have previously reported that the RLS prevalence in a Danish blood donor 
population was higher among women than among men (7.5% in women versus 4.5% in men), and that 
RLS-related risk factors differed according to sex [18]. Therefore, it is possible that RLS affects men 
and women differently and that the magnitude of consequences varies according to the intensity of the 
disorder. Hence, potential negative consequences of suffering from RLS need to be studied in a large 
population sample that can be classified as otherwise healthy. As blood donors are required to be 
generally healthy and not subjected to medical treatment to be eligible for donation [19], they are ideal 
for studying such consequences. Moreover, because it is well established that blood donors have an 
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increased risk of becoming iron deficient, which in turn may lead to RLS [20, 21], it is imperative that 
detrimental links to RLS in blood donors is clarified. However, it should be noted that we have 
previously shown that iron deficiency does not increase the risk of reduced HRQL among Danish blood 
donors [22]. 
The purpose of this study was therefore to extend current knowledge by examining potential negative 
consequences of RLS (reduced MCS, reduced PCS, and increased depression), stratified according to 
sex and symptom intensity, while taking relevant covariate factors into account, in a large population of 
otherwise healthy Danish blood donors. 
1. Methods 
1.1 Data 
The present study is based on data from the Danish Blood Donor Study (DBDS) (www.dbds.dk), which 
is an ongoing national cohort of Danish blood donors with only 5% of the invited donors declining to 
participate. The cohort is described in detail elsewhere [23]. Briefly, the DBDS utilizes the 
infrastructure in the Danish blood banks to collect data for a range of specific and general health 
research purposes. Blood donors who donated two or more times in a Danish blood bank were asked to 
participate in the study. Upon inclusion into the study, each participant filled out a comprehensive 
health related electronic questionnaire. This questionnaire provided information on RLS, HRQL, 
depressive symptoms, and previous depression diagnoses. Moreover, the participants gave permission 
for their questionnaire data to be linked with data from the Danish population registers. Before donating 
blood, Danish blood donors are asked a number of screening questions to asses if they felt completely 
well, if they have taken any medications, or if they have been sick since their last donation. These 
screening questions cover both physical and mental health, which assures that the donors are generally 
healthy upon each donation they make, and therefore also upon inclusion into this study as well. 
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1.1.1 Ethics statement 
Oral and written informed consent was obtained from all participants. The study was approved by The 
Scientific Ethical Committee of Central Denmark (M-20090237). Additionally, the biobank and 
research database have been approved by the Danish Data Protection Agency (2007-58-0015). 
1.1.2 Identifying restless legs syndrome (RLS) 
RLS was assessed using the 10 item Cambridge-Hopkins RLS questionnaire (CH-RLSq), the only tool 
validated in a population of blood donors [24] (diagnostic sensitivity 87.2% and specificity 94%) [25], 
as well as recommended as one of the most accurate scales [26]. When the CH-RLSq was translated 
from English to Danish it was done by three persons independently of each other, and then merged into 
a “consensus” translation by one of the translators. Subsequently, the Danish versions were translated 
back into English by three individuals who were not familiar with the original English version of the 
questionnaire. Again, the three translations were merged by one of the translators. The translated 
English versions were evaluated by two native English speaking experts in RLS. Both the translated 
English version and the reverse translated Danish version of the questionnaire were evaluated by a 
bilingual Danish expert in neurology and sleep medicine. Based on these evaluations, the final version 
was completed. Furthermore, participants with RLS symptoms rated their severity on a four point Likert 
scale, while they rated their frequency on a six point Likert scale ranging from “not uncomfortable” to 
“extremely uncomfortable” and from “one day a month” to “every day”, respectively. Further, 
participants experiencing RLS symptoms were asked about their quality of sleep (four point Likert 
scale) and experience of involuntary jerking of the legs during sleep (binary measure).  
1.1.3 Self-rated health-related quality of life (HRQL) 
HRQL was measured using the validated 12-item short form health survey (SF-12) [27], an abbreviated 
version of the 36-item short form standardized health survey (SF-36), which has been validated in the 
Danish language [27]. SF-36 was developed for population survey and is the most commonly used 
measure of HRQL [28]. SF-12 measures a mental and physical component score (MCS and PCS). Each 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8 
 
score comprises four subscales. MCS comprises of vitality, social functioning, role-emotional, and 
mental health. PCS comprises of physical functioning, role-physical, bodily pain, and general health. 
The SF-12 responses were scored assigning weights to each item (ranging from -16.15395 to +4.61446) 
and adding the sum of the items to a constant (57.65693 and 60.58857) for PCS and MCS, respectively 
as recommended by Quality Metric Inc. [28]. The lower the MCS and PCS scores, the worse the 
components of the HRQL are experienced by the respondent. MCS and PCS have both been normalized 
in a Danish background population to a mean MCS of 52.8 (SD, 8.3) and a mean PCS of 51.0 (SD, 8.1) 
[27]. 
 
1.1.4 Depressive symptoms 
Information on current depressive symptoms was collected as self-report using the Major Depression 
Inventory (MDI), which has been validated in the Danish language [29-31]. The MDI covers both the 
ICD-10 and the DSM-IV symptoms of depression [32]. The MDI was used to appraise the presence of 
the ten depressive symptoms within the last two weeks prior to inclusion into the study with depressive 
disorder classified as an MDI score of more than 20 [29]. As supplementary analyses the participants 
were asked if they had ever been diagnosed with depressive disorder by a medical doctor. This question 
was used to assess whether previous clinical depression at some point in the participants’ lives was 
associated with current RLS.  
 
1.1.5 Covariates 
The questionnaire provided information on body mass index (BMI), smoking status and alcohol 
consumption. The National Education Register of Denmark provided data on the participants’ highest 
achieved educational level. Information on donation frequency for the past three years was collected 
from blood bank registers across Denmark. Linking of individual level data from the register with data 
from the questionnaire had high validity, due to the use of unique Danish Civil Registration Numbers 
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[33].  
 
1.2 Statistical analyses  
Statistical analyses were conducted using Stata/SE 14.0, StataCorp, College Station, TX. Normally 
distributed data were described with means and standard deviations (SD). MCS and PCS were 
dichotomized using the 10th and the 25th percentile scores as cutoffs to define participants with low or 
reduced HRQL, respectively. Low MCS and Low PCS were defined as the lowest 10th percentile of 
scores because this definition has been used previously when examining the probability of low HRQL 
in the DBDS population [22]. The MDI score was dichotomized using a score of 20 or above to define 
participants with depressive disorder. Low educational level was defined as high school/vocational 
course or lower. Frequent alcohol consumption was defined as reports of alcohol consumption “several 
times a week” or “every day”. Distributions of all binary variables among the participants were 
described in percentages and statistically significant differences were investigated by t-tests for 
normally distributed data and by chi2 tests for dichotomous data. In order to obtain normal distributions 
of the scales before examining statistically significant differences in scores, a power transformation of 
five was applied to MCS and PCS, and the MDI scale was log-transformed. Difference in answers to 
specific questions on the SF-12 and the MDI scale between RLS cases and non-RLS cases was 
examined using t-tests. Multivariable logistic regression analyses were applied to assess the probability 
of scoring low and reduced PCS and MCS, classifying with depressive disorder, and having a previous 
diagnosis of depression among participants with RLS compared to participants without. Age, BMI, 
smoking, frequent alcohol consumption, low educational level, and number of whole blood donations 
three years prior to inclusion into this study were all considered possible covariates of the associations 
[21, 34, 35] and were entered in all multivariable regression analyses as binary variables, except for 
donation frequency, age, and BMI, which were entered as continuous variables.  Analyses assessing the 
relationship between RLS and a previous depressive disorder diagnosis, and reduced MCS/PCS are 
presented as supplementary in the Appendix. Additionally, multivariable logistic regression models 
were applied among RLS cases to examine the effect of quality of sleep (poor vs. good) and involuntary 
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leg movements during sleep (ILM) (yes vs. no) on HRQL and depressive disorder. These analyses on 
the effect of sleep only comprised RLS cases. Thus, to maintain the statistical power they were adjusted 
for sex, but not stratified. 
2. Results 
2.1 Characteristics of the study population  
Complete data were available for 13,419 men and 11,288 women, of whom 1,298 (5.3%) were 
classified as suffering from RLS (4.0% men and 6.7% women). 46.5% of the RLS cases characterized 
their symptoms as moderately to extremely uncomfortable (severe) and 30.7% experienced the 
symptoms more than two times a week (frequent). Overall, there were 221 participants (0.9%) who had 
RLS symptoms that were characterized as both severe and frequent, while 1,077 (4.4%) presented with 
mild or infrequent RLS symptoms.  
A total of 27,315 participants were recruited to this study from May 1 2015 to February 1 2017. Among 
these, 891 were missing at least one item of the CH-RLSq, 626 were missing information on covariates 
(education, lifestyle, and donation history), 791 and 605 were missing at least one item on the MDI and 
SF-12, respectively, and were therefore excluded from the study. Finally, 24 participants who would 
otherwise characterize with RLS were excluded because they answered “yes” or “don’t know” to both 
of the following two questions from the CH-RLSq “Are these feelings ever due to muscle cramps?” and 
“If so, are they always due to muscle cramps?” and 6 RLS cases were excluded due to missing 
information on frequency and severity of RLS symptoms, quality of sleep, and ILM. Thus, analyses 
were conducted on 24,707 study participants with complete data available. We investigated interactions 
between covariates and found the effect of all covariates (except low education) on RLS to be 
significantly correlated with sex (P<0.001). The subsequent analyses were therefore stratified on sex. 
The prevalence of depressive disorder, previous depression diagnosis, and poorer MCS/PCS was higher 
among RLS cases compared to participants without RLS (P<0.001) (Table 1).  
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2.2 Differences in scores between individuals with and without restless legs syndrome (RLS)  
The median MCS score was 56.9 (25th and 75th percentiles: 52.9, 58.9) for women and 57.5 (53.9, 58.9) 
for men. The median PCS score was 56.6 (25th and 75th percentiles: 54.5, 57.9) for women and 56.6 
(54.4, 57.7) for men. The median MDI score was 4 (25th and 75th percentiles: 2, 7) for women and 4 (1, 
7) for men. We found lower median scores of the MCS and PCS, respectively, among RLS cases with 
all levels of symptom intensity among both men and women; they were however, statistically 
insignificant for PCS score among male RLS cases with mild or infrequent symptoms. The lowest 
median MCS score was observed among participants who reported frequent experience of RLS 
symptoms among both men and women. Men with severe RLS symptoms and women with frequent 
symptoms had the lowest median of PCS scores (Table 2). Not one specific question on the SF-12 
caused the lower MCS and PCS scores in RLS cases. Finally, we found statistically significant higher 
Table 1. Demographic and clinical features of the study population 
Characteristic× RLS No RLS symptoms  
 
N=1,298 N=23,409 P * 
Female sex (%) 58.2 45.0 <0.001 
Age (mean ±SD) 42.2 (±12.2) 41.4 (±12.7) <0.01 
Low MCS (%) 14.3 9.8 <0.001 
Reduced MCS (%) 32.4 24.5 <0.001 
Low PCS (%) 14.6 9.6 <0.001 
Reduced PCS (%) 33.3 24.5 <0.001 
Depressive disorder (%) 5.6 2.9 <0.001 
Previous diagnosis with depressive disorder (%) 12.2 7.5  <0.001 
Body mass index (Mean ±SD) 25.8 (4.3) 25.7 (4.1) 0.287 
Low education (%) 56.9 54.3 0.073 
Smoker (%) 15.3 12.8 <0.01 
Frequent alcohol consumption (%) 38.1 35.5 0.065 
Donation frequency for the past 3 years (mean, SD) 5.2 (2.5) 5.4 (2.6) <0.001 
×Low mental health-related quality of life (MCS) and low physical health related quality of life (PCS) were defined using the 
10th percentile as cutoff and reduced MCS and PCS were defined using the 25th percentile as cutoff.  Depressive disorder was 
defined as a Major depression inventory score (MDI) > 20 and previous diagnosis with depressive disorder was defined as a 
diagnosis given by a medical doctor at some point in the participants’ lives. 
*Age and MDI were log-transformed and a power five transformation was applied to MCS and PCS in order to obtain normal 
distribution before examining significant differences between RLS and non-RLS sufferers. 
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mean MDI scores among both female and male RLS cases with all levels of symptoms severity (Table 
2). No specific questions on the MDI scale caused this. 
 
Table 2. Differences in mental- and physical health-related quality of life scores (MCS and PCS) and major 
depression inventory score (MDI) according to Restless Legs Syndrome (RLS) status 
T-tests* 
 
Women (n controls = 10,532) 
 
Men (n controls = 12,877) 
 Cases Non-cases  Cases Non-Cases 
 Score      Symptom severity Median 
 (25th;75th percentiles) P n (cases)  
Median 
 (25th;75th percentiles) P n (cases) 
MCS  
 
 
All cases of 
RLS 
56.2 
(50.9;57.8) 
56.9 
(52.9;58.9) 
<0.001 756  56.5 (51.7;57.9) 
57.6 
(54.0;58.9) 
<0.001 542 
Frequent×× 
55.3 
(47.1;58.6) <0.001 225  
55.4 
(49.5;57.7) <0.001 174 
Severe 56.7 (51.2;58.6) 0.011 392  
56.2 
(50.9;58.6) <0.001 212 
Infrequent or 
mild 
56.3 
(51.3;57.7) <0.001 609  
56.7 
(52.4;58.2) <0.001 468 
PCS  
 
All cases of 
RLS 
56.2 
(53.2;59.3) 
56.6 
(54.6;57.9) 
<0.01 756  56.1 (53.2;57.5) 
56.6 
(54.5;57.7) 
<0.001 542 
Frequent×× 
55.4 
(50.5;57.0) <0.01 225  
55.6 
(52.1;57.6) <0.001 174 
Severe 55.9 (52.8;57.5) <0.001 392  
55.4 
(51.8;57.0) <0.001 212 
Infrequent or 
mild 
56.4 
(53.5;57.6) <0.01 609  
56.4 
(53.8;57.6) 0.084 468 
MDI 
 
All cases of 
RLS 5 (3;8) 
4 (2;7) 
<0.01 756  5 (2;8) 
4 (1;7) 
<0.01 542 
Frequent×× 6 (3;10) <0.01 225  6 (3;11) <0.01 174 
Severe 5 (3;8) <0.01 392  5 (2;10) <0.01 212 
Infrequent or 
mild 5 (3;8) 0.01 609  5 (2;8) <0.01 468 
**Mental health-related quality of life score (MCS) and Physical health related quality of life score (PCS) were transformed 
using a power transformation of five, while the Major Depression Inventory Score (MDI) was log-transformed to obtain a 
normal distribution before conduction T-tests 
×× Frequent RLS symptoms were defined as symptoms occurring two to three times a week or more 
 
2.3 Restless legs syndrome (RLS) and the mental component score of health related quality of life 
(MCS)  
Participants suffering from RLS were more likely to have a low MCS (women: OR=1.61 P<0.001; 
men: OR=1.79 P=<0.001) (Figures 1 and 2). Moreover, the probability of low MCS was highest among 
participants with frequent RLS symptoms (women: OR=2.54 P<0.001; men: OR=2.51 P<0.001). Even 
RLS sufferers with mild or infrequent symptoms also had an increased probability of low MCS 
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(women: OR=1.46 P<0.001; men: OR=1.52 P<0.001). Finally, participants with RLS were more likely 
to have a reduced PCS (Appendix, Table 5). 
2.4 Restless legs syndrome (RLS) and the physical component score of health related quality of life 
(PCS)  
Both men and women suffering from RLS were more likely to have a low PCS (women: OR=1.49 
P<0.001; men: OR=1.53 P<0.001) (Figure 1 and 2). Severe RLS symptoms were associated with a 
more than doubled prevalence of low PCS among both men (OR=2.35 P<0.001) and (OR=2.75 
P<0.001). Moreover, men with mild or infrequent RLS had an increased probability of having a low 
PCS (OR=1.33 P<0.048) (Figure 1). We found no association between infrequent or mild RLS and low 
PCS among women (Figure 2). Furthermore, participants with RLS were more likely to have a reduced 
PCS regardless of symptom intensity (Appendix, Table 5). 
2.5 Restless legs syndrome (RLS) and depressive disorder  
We found that men and women with severe RLS symptoms had 3.60 and 4.08 fold higher odds for 
being classified with depressive disorder compared to non-RLS sufferers, respectively (both sexes, 
P<0.001) (Figure 1 and 2). Furthermore, participants with mild or infrequent RLS symptoms had a 
more than 50% increased probability of classifying with depressive disorder compared to non-RLS 
sufferers (women: OR=1.59 P<0.015; men: OR=1.79 P<0.020) (Figure 1). We found that 8.2% of the 
study participants were diagnosed with a depressive disorder by a medical doctor. Our analyses showed 
an increase in RLS occurrence among men and women with a previous diagnosis. However, there was 
no association between having a previous diagnosis and currently suffering from RLS with mild or 
infrequent symptoms among men (Appendix, Table 6). 
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Figure 1. Association of restless legs syndrome (RLS) and depressive disorder and health related 
quality of life, respectively, among men 
 
Legend: Displaying odds ratios (OR) with 95% confidence intervals for depressive disorder, low mental 
component score (MCS), and low physical component score (PCS) (SF-12©) according to frequency and severity 
of RLS symptoms (Adjusted for age, body mass index, alcohol consumption, smoking status, educational level, 
and donation frequency for the past three years) 
Figure 2. Association of restless legs syndrome (RLS) and depressive disorder and health related 
quality of life, respectively, among women 
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Legend: Displaying odds ratios (OR) with 95% confidence intervals for depressive disorder, low mental 
component score (MCS), and low physical component score (PCS) (SF-12©) according to frequency and severity 
of RLS symptoms (Adjusted for age, body mass index, alcohol consumption, smoking status, educational level, 
and donation frequency over the past three years) 
2.6 Quality of sleep and involuntary leg movements during sleep  
Poor quality of sleep and ILM were reported by 22.6% and 22.1% of RLS cases, respectively. We 
found that poor quality of sleep was associated with an increased risk of depressive disorder and low 
MCS among participants with RLS (P<0.001), and with an increased risk of low PCS among women 
with RLS (Table 3). The risk estimates changed marginally when adjusted for ILM. Furthermore, we 
found that RLS cases reporting frequent and severe symptoms were more likely to have depressive 
disorder (P<0.01), low MCS (P<0.001), and low PCS (P<0.01) compared to cases reporting infrequent 
or mild symptoms. Quality of sleep and ILM were included in these regression models, ORs attenuated 
and P values increased (Table 4). Moreover, we found that poor quality of sleep was associated with 
reduced MCS and reduced PCS among participants with RLS (P<0.01) (Appendix, Tables 7 and 8). 
Furthermore, the MDI scale comprises a question asking; “Did you have difficulties sleeping at night 
for the past two weeks”, which is classified as a accompanying symptom in depressive disorder. For an 
accompanying symptom to be considered present the participant must answer that they experience the 
symptom “more than half the time” or even more frequently. This specific symptom was present in 
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49.5% of participants that classified with depression, and it was not more prominent in RLS cases with 
depression compared to non-RLS cases with depression. However, overall the prevalence of the 
symptom was more than double among RLS cases (9.6%) compared to non-RLS cases (4.5%), 
regardless of whether they were classified with a depression or not (P<0.001). Similarly, the symptom 
was more prevalent among RLS cases reporting severe symptoms (18.6%) compared to RLS cases 
reporting mild symptoms (7.7%) (P<0.001). 
  
 
 
Table 3. Multivariable logistic regression analyses comprising all donors suffering from restless 
legs syndrome (RLS) 
 
Men (n=542)  Women (n=756) 
 
 Model 1* Model 2**  Model 1* Model 2** 
Logistic regression  OR P OR P value OR P OR P 
Comparison groups: poor quality of sleep vs. good quality of sleep 
Low MCS×  
 
3.74 <0.001 3.71  <0.001 3.75 <0.001 3.72 <0.001 
Low PCS× 
 
1.70 0.060 1.63 0.083 2.60 <0.001 2.57 <0.001 
depressive disorder×  4.40 <0.001 4.19 <0.01 9.22 <0.001 9.20 <0.001 
×Low mental health-related quality of life (MCS) and physical health related quality of life (PCS) were defined 
using the 10th percentile as cutoff. Depressive disorder was defined as a Major Depression Inventory Score (MDI) 
score > 20. 
*Adjusted for age, body mass index, alcohol consumption, smoking status, educational level, and donation 
frequency for the past three years 
**Adjusted for age, body mass index, alcohol consumption, smoking status, educational level, donation frequency 
for the past three years, and involuntary leg movements during sleep 
 
 
Table 4.  The probability of low MCS, PCS and depression, respectively, among  
participants with restless legs syndrome (RLS) 
N=1,298 RLS cases 
 Model 1* Model 2** 
Characteristic (%)  OR (95 % CI) P OR (95 % CI) P 
Comparison groups: Frequent and severe RLS vs. infrequent or mild RLS 
Low MCS× 2.05 (1.39-3.05) <0.001 1.71 (1.14-2590) 0.010 
Low PCS× 2.08 (1.45-2.99) <0.01 1.76 (1.21-2.57) <0.01 
Depression× 2.57 (1.47-4.51) <0.01 1.99 (1.11-3.60) 0.023 
×Low mental health-related quality of life (MCS) and physical health related quality of life (PCS) 
were defined using the 10th percentile as cutoff. Depression was defined as a Major Depression 
Inventory score (MDI) > 20. 
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3. Discussion 
The present findings showed that both men and women with RLS had higher odds for experiencing low 
MCS, low PCS, and depressive disorder in a large population that was not affected by other diagnoses 
or medical treatments. Our findings also indicated that higher severity and frequency of RLS symptoms 
increases the odds for detrimental links to the disorder, and that this effect varied between sexes. Thus, 
it is evident that RLS is a troublesome disorder with severe consequences. Furthermore, we observed 
that RLS sufferers who reported poor quality of sleep had higher odds for depressive disorder and low 
MCS compared to RLS sufferers who reported good quality of sleep. Among women with RLS 
reporting poor quality of sleep we also observed higher odds for low PCS. This could mean that quality 
of sleep plays an important role in the observed associations, and maybe also that this role differs 
between sexes. 
The present findings together with our previous report of sex-related differences in RLS-associated 
demographic and lifestyle factors [18] indicate that the detrimental links to RLS vary between sexes. 
Findings from other previous studies support this suggestion. RLS has proved to be an independent 
predictor of HRQL in several studies [1, 6, 7, 9, 11-13, 36, 37]. A Swedish study, including a random 
sample of 5,000 women (aged 25-64) also using the SF-12 reported that RLS affected MCS more 
negatively than PCS [13]. This is in line with our findings in both men and women. Specifically, we 
observed no association between RLS and low PCS among women with infrequent or mild symptoms. 
In contrast, a study from the USA discovered that the burden of RLS was more significant on PCS than 
on MCS [9], which included a significantly smaller sample size than the present study (n=158) and 
included a nationwide random sample of US adults.  
RLS has also been found to be associated with psychiatric and psychological disorders at long term [38, 
39], and to further emphasize the serious nature of our findings, it should be noted that previous studies 
*Adjusted for sex, age, body mass index, alcohol consumption, smoking status, educational level, 
and  donation frequency for the past three years 
** Adjusted for sex, age, body mass index, alcohol consumption, smoking status, educational level, 
and  donation frequency for the past three years,  and quality of sleep and  involuntary leg 
movements during sleep 
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have reported that HRQL scores in RLS sufferers resemble HRQL scores among patients with other 
chronic disorders, such as type 2 diabetes, osteoarthritis, Parkinson’s disease, narcolepsy, multiple 
sclerosis, and stroke [7, 37]. Happe et al. (2009) additionally underlined the severity of the RLS 
disorder, by stating that the impact that RLS has on HRQL is equal to or even worse than the impact of 
other chronic neurological disorders [7]. Moreover, Allen et al. (2005) found that RLS was associated 
with poorer SF-36 score and reported that the reduction in score was similar to the one seen in clinical 
depression cases [8, 37]. Our findings support this comparison as we found that RLS cases were more 
likely to be classified with depressive disorder, which is in line with other reports of high prevalence of 
depressive disorder among RLS sufferers [5, 8, 15, 40]. We observed that RLS sufferers with severe 
and infrequent symptoms had higher odds for depression compared to RLS sufferers reporting mild or 
infrequent symptoms. Castillo et al. (2014) reported a similar increased risk of depressive disorder 
among individuals with severe RLS symptoms compared to individuals with mild to moderate 
symptoms [40]. Moreover, participants with mild or infrequent RLS symptoms were more likely to be 
classified with depressive disorder than participants without RLS. This suggests that all RLS cases, 
regardless of symptom severity and frequency, warrant medical attention. This has practical 
significance for the management of the RLS disorder.  
The pathogenesis of the associations reported is still unknown and plausibly multifactorial. Quality of 
sleep is an important aspect of individuals’ general health that has continuously been reported as the 
most troublesome morbidity of RLS [8, 12, 14]. We found that RLS sufferers reporting poor quality of 
sleep were more likely to have a low or reduced MCS and classify with depressive disorder, compared 
to RLS sufferers with good quality of sleep. Similarly, women with RLS reporting poor quality of sleep 
were more likely to have low PCS compared to female RLS cases reporting good quality of sleep. 
These findings were robust to adjustment for ILM. Furthermore, RLS cases with frequent and severe 
symptoms had statistically insignificant higher odds for low MCS, low PCS, and increased depressive 
compared to participants with infrequent or mild symptoms. However, the ORs attenuated and the P 
values increased when quality of sleep and ILM were entered into the logistic regression model. This is 
in line with reports by Koo et al. (2016), who found that insomnia was most prevalent among 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
19 
 
individuals with severe RLS symptoms [8]. As we did not have information on quality of sleep or ILM 
for non-RLS sufferers it was not possible to assess whether these factors were actual mediators of the 
associations found in this study. However, interpreting our findings according to previous reports of 
effect mediation and moderation of the RLS-depressive disorder relationship [8], it seems that quality of 
sleep plays an important role in the associations shown in this study, at least to some extent. Another 
explanation for the observed association between RLS and depression could be the overlap of 
symptoms between the two disorders. Poor quality of sleep related to RLS may result in irritable mood, 
agitation, and problems with concentrating [39], which could make an individual with RLS classify 
with depressive disorder. Finally, it is plausible that RLS symptoms, including uncomfortable or painful 
sensations combined with the constant urge to move caused the decreased PCS in RLS cases. 
The main strength of the present study was the size of the cohort and the data available. To our 
knowledge, this study is the first to apply the CH-RLSq, SF-12 and MDI in a generally healthy cohort 
of this size. The tools applied in this study are widely used and validated scales [24, 27, 29, 32]. Using 
the CH-RLSq assured correct identification of RLS [26]. Moreover, it was reported that the MDI has 
high content validity, as the scale isolates the most applicable items for negative wellbeing [32], and 
there is evidence that the clinical validity of the MDI as a unidimensional severity depression scale is 
high [29]. Furthermore, SF-12 is a generic tool, meaning it can be used to measure HRQL in population 
groups regardless of their age, sex, or health status. However, a specific RLS-related quality of life 
questionnaire does exist, called the Restless Legs Syndrome Quality of Life Instrument [4]. This 
questionnaire includes items that are specific to RLS symptoms, primarily regarding sedentary activities 
and insomnia [41]. Our results indicate that poor sleep quality plays a role in the associations found in 
this study. Thus, the odds ratios reported here were possibly underestimations of the true association 
between RLS and reduced HRQL. The questions used in this study to assess intensity of the RLS 
disorder was imbedded in a larger health-related questionnaire administered to blood donors. In order to 
be considerate of the blood donors’ time we had to limit the number of questions assessing the severity 
and frequency of symptoms among RLS cases to two questions. It would have provided a broader 
insight into the symptoms if we had applied the International RLS Severity Scale or the RLS-6 scale, 
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which assesses the severity of the disorder using ten and six questions, respectively. Moreover, MCS has 
previously been used as a screening tool to identify people with depressive disorder [28, 42]. This means, 
that the links we found between RLS and MCS and MDI score, respectively, are likely to be 
expressions of the same association.  
As previously mentioned, the associations found in this study cannot be attributed to differential 
morbidities, especially ones requiring medical treatment because the donors are required to be healthy. 
Notably, patients taking antidepressants are not eligible for donation, which is a significant 
methodological strength. Previous studies examining the RLS-depression link might be biased, because 
it is reported that antidepressants can provoke or exacerbate RLS symptoms [15]. Thus, the use of 
antidepressants is a potential confounding factor in other studies. Additionally, it is plausible that the 
most severe RLS cases do not become blood donors due to the selection of generally healthy 
individuals. Furthermore, it should also be noted that because data examined in this study were cross-
sectional we were not able to make any conclusions on directionality or causality of the observed 
associations. Similarly we cannot conclude on long term health effects of RLS. In our analyses we 
adjusted for sociodemographic factors (age and sex), socioeconomics (education), and lifestyle factors 
(BMI, smoking, alcohol consumption, and number of whole blood donations for the past three years), 
which is a specific strength. Nonetheless, this study could be affected by “the internal healthy donor 
effect”. The healthy donor effect describes the fact that blood donors represent a healthy subgroup of 
the general population, and that donors who donate frequently are generally healthier than infrequently 
donating donors [19]. This means that it is possible that donors suffering from severe RLS has either 
stopped donating or donated fewer times than donors without RLS or with a mild case of the disorder. 
Hence, the internal healthy donor effect may have masked any potential negative effects of donation-
induced iron deficiency on both RLS and related consequences. 
Thus, our study is susceptible to misclassification bias due to the self-report nature of the questionnaire 
data. This particularly applies to the assessment of ILM presence. It would have been more reliable had 
we used EMG or actigraphy measurements or asked about ILM during wakefulness instead of during 
sleep to exclude potential recall-bias. Overall, it is possible that participants misunderstood some of the 
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questions. Furthermore, is also possible that some participants might have under or over reported health 
related behaviors. However, because validated questions and scoring systems were used, we do believe 
that the potential misclassification would be random and not bias the results. 
 
4. Conclusions 
In conclusion, this study provides evidence that blood donors, who comprise a population with a high 
level of general health that is not biased by other diagnoses or by any medications, suffering from RLS, 
are more likely to experience poor HRQL and to be classified with depressive disorder compared to 
people without RLS. HRQL is a direct measure of individuals’ subjective experience of their wellbeing, 
and it is reported to be a predictor of future morbidity and mortality in the general Danish population 
[43]. Thus, RLS appears to be a significantly troublesome disorder, even when the symptoms are 
categorized as either infrequent or mild. Even so, RLS is still thought to be underdiagnosed [44], 
probably due to lack of knowledge of its existence. The findings of this study suggest that the majority 
of RLS cases warrant medical attention and that practical management of RLS should include 
interventions that aim at increasing the HRQL and decreasing the occurrence of depressive symptoms 
among these patients. 
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Supplemental material 
Table 5. Multiple logistic regression analyses with Restless Legs Syndrome (RLS) as the Independent 
variable 
Logistic regression  Men (n controls=12,877)  Women (n controls=10,532) 
 
 Multi adjusted*  Multi adjusted* 
 
Comparison groups Odds ratio P value n(cases)  Odds ratio P value n(cases) 
 Low MCS×  RLS: yes vs. no 1.79 <0.001 542  1.61 <0.001 756 
 
 
Frequent symptoms×× vs. no RLS 2.52 <0.001 174  2.54 <0.001 225 
Severe  RLS vs. no RLS 2.45 <0.01 212  1.81 <0.001 392 
Infrequent or mild RLS symptoms 
vs. no RLS 1.52 <0.001 468  1.46 <0.001 609 
Reduced 
MCS× 
 
RLS: yes. vs. no 1.61 <0.001 542  1.41 <0.001 756 
Frequent symptoms×× vs. no RLS 2.23 <0.001 174  2.10 <0.001 225 
Severe RLS vs. no RLS 2.09 <0.001 212  1.46 <0.001 392 
Infrequent or mild RLS symptoms 
vs. no RLS 1.45 <0.001 468  1.30 <0.01 609 
Low PCS× RLS: yes. vs. no 1.53 <0.001 542  1.49 <0.001 756 
Frequent symptoms×× vs. no RLS 2.10 <0.001 174  2.75 <0.001 225 
Severe RLS vs. no RLS 2.35 <0.001 212  1.58 <0.01 392 
Infrequent or mild RLS symptoms 
vs. no RLS 1.33 0.048 468  1.21 0.151 609 
Reduced 
PCS× 
RLS: yes. vs. no 1.47 <0.001 542  1.50 <0.001 756 
Frequent symptoms×× vs. no RLS 1.75 <0.001 174  2.03 <0.001 225 
Severe RLS vs. no RLS 2.07 <0.001 212  1.51 <0.001 392 
Infrequent or mild RLS symptoms 
vs. no RLS 1.31 <0.01 468  1.42 <0.001 609 
Depression× 
 
RLS: yes. vs. no 2.32 <0.001 542  1.87 <0.001 756 
Frequent symptoms×× vs. no RLS 3.60 <0.001 174  4.08 <0.001 225 
Severe RLS vs. no RLS 3.89 <0.001 212  2.09 <0.01 392 
Infrequent or mild RLS symptoms 
vs. no RLS 1.79 0.020 468  1.59 0.015 609 
×Low mental health-related quality of life (MCS) and physical health-related quality of life (PCS) were defined using the 10th 
percentile as cutoff and reduced MCS and PCS were defined using the 25th percentile as cutoff. Depression was defined as a 
Major Depression Iventory Score>20. 
×× Frequent RLS symptoms was defined as symptoms occurring 2 – 3 times a week or more 
*Adjusted for age, body mass index, alcohol consumption, smoking status, educational level, and donation frequency for the 
past three years 
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Table 6. Multivariable linear and logistic regression analyses with clinical depression as the 
independent variable and Restless Legs Syndrome (RLS) as the dependent variable 
  
Men (n controls=10,532)  Women (n controls=12,877) 
 
 Multi adjusted*  Multi adjusted* 
Logistic regression  OR P value n (cases)  OR P value n (cases) 
Previous depression-diagnosis× (yes vs. no)    392    608 
RLS  1.62 <0.01 756  1.57 <0.001 542 
Frequent RLS symptoms××  2.05 <0.01 225  2.00 <0.001 174 
Severe RLS symptoms 
 2.03 <0.01 392  1.75 <0.001 212 
Infrequent or mild RLS symptoms  
 1.39 0.071 609  1.48 <0.01 468 
×Previous depression-diagnosis was defined as a depression-diagnosis given by a medical doctor at some point in 
the participants’ lives. 
×× Frequent RLS symptoms was defined as symptoms occurring 2 – 3 times a week or more 
*Adjusted for age, body mass index, alcohol consumption, smoking status, educational level, and donation 
frequency for the past three years 
 
Table 7. Multivariable logistic regression analyses comprising all donors suffering from Restless 
Legs Syndrome (RLS) 
 
Men (n=542)  Women (n=756) 
 
 Model 1* Model 2**  Model 1* Model 2** 
Logistic 
regression 
Self-reported quality 
of sleep 
OR P 
value OR P value OR 
P 
value OR P value 
Reduced MCS× Poor vs. good 4.12 <0.001 4.11 <0.001 3.85 <0.001 3.80 <0.001 
Reduced PCS× Poor vs. good 1.75 0.012 1.72 0.014 1.15 0.440 1.16 0.427 
×Reduced mental health-related quality of life (MCS) and physical health-related quality of life (PCS) were defined 
using the 25th percentile as cutoff.  
*Adjusted for age, body mass index, alcohol consumption, smoking status, educational level, and donation 
frequency for the past three years 
**Adjusted for age, body mass index, alcohol consumption, smoking status, educational level,  donation frequency 
for the past three years, and periodic leg movements during sleep 
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Table 8.  Multivariable logistic regression analyses comprising all donors suffering 
from Restless Legs Syndrome (RLS) 
N=1,298 RLS cases  Model 1* Model 2** 
Characteristic (%)  OR (95 % CI) P value OR (95 % CI) P value 
Comparison groups: Frequent and severe RLS vs. infrequent or mild RLS 
Reduced MCS× 1.60 (1.16-2.19) <0.001 1.33 (0.95-1.87) 0.092 
Reduced PCS× 1.56 (1.15-2.11) <0.01 1.42 (1.04-1.94) 0.026 
×Reduced mental health-related quality of life (MCS) and physical health-related quality of life 
(PCS) were defined using the 25th percentile as cutoff.  
*Adjusted for sex, age, body mass index, alcohol consumption, smoking status, educational level, 
and donation frequency for the past three years 
**Adjusted for sex, age, body mass index, educational level, smoking status, alcohol 
consumption,  donation frequency for the past three years, and quality of sleep and involuntary 
leg movements during sleep 
 
